Loading chat...
MN HF3603
Bill
Status
Introduced
2/21/2022
Primary Sponsor
Dave Lislegard
Click for details
AI Summary
- Appropriates $20,000,000 from the general fund in fiscal year 2023 to the Board of Regents of the University of Minnesota
- Funds are designated for competitive grants to conduct research into prevention, treatment, causes, and cures of amyotrophic lateral sclerosis (ALS)
- This is a onetime appropriation with unencumbered balances authorized to remain available until July 1, 2026
Legislative Description
Amyotrophic lateral sclerosis research funding provided, and money appropriated.
Last Action
Authors added Poston and Masin
3/28/2022
Committee Referrals
Higher Education Finance and Policy2/21/2022
Full Bill Text
No bill text available